Emil D. Kakkis - 31 Dec 2021 Form 5 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
President & CEO, Director
Signature
/s/ Karah Parschauer, attorney-in-fact
Issuer symbol
RARE
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
01 Feb 2022, 12:41:46 UTC
Previous filing
18 Oct 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Gift $0 -50,000 -2.2% $0.000000 2,209,741 10 Dec 2021 By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200
holding RARE Common Stock 594,347 31 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.